Effects of sleeve gastrectomy surgery with modified jejunoileal bypass on body weight, food intake and metabolic hormone levels of rats

Abstract

This study examined the effects of a combined surgery of sleeve gastrectomy (SG) and modified jejunoileal bypass (JIB) on the body weight, food intake, and the plasma levels of active glucagon-like peptide-1 (GLP-1) and total ghrelin of rats. Rats were divided into 3 groups in terms of different surgical protocol: SG-JIB (n=12), SG (n=12), JIB (n=12) and sham surgery groups (n=10). In SG-JIB group, rats was subjected to sleeve gastrectomy and end to side anastomosis of part of the jejunum (25 cm from the ligament of Treitz) to the ileum 25 cm proximal to the cecum. The body weight and food intake were evaluated during 10 consecutive weeks postoperatively. The levels of active GLP-1 and total ghrelin in the plasma of the rats were measured by ELISA assay. The results showed that the SG-JIB treated rats relative to SG- or JIB-treated ones produced a sustained reduction in food intake and weight gain. The level of active GLP-1 was elevated and total ghrelin level decreased in SG-JIB-treated rats as compared with SG- or JIB-treated ones. It was concluded that SG-JIB could efficiently reduce the body weight and food intake, alter obesity-related hormone levels of the rats, indicating that SG-JIB may be potentially used for the treatment of obesity.

Keywords

sleeve gastrectomy / modified jejunoileal bypass / body weight / food intake / glucagon-like peptide-1 / ghrelin

References

[1] MattarS.G.. Lifting the unbearable weight of morbid obesity. Ann Surg, 2008, 247(1): 28-29

[2] CawleyJ., RizzoJ.A., HaasK.. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med, 2007, 49(12): 1317-1324

[3] PrenticeA.M.. The emerging epidemic of obesity in developing countries. Int J Epidemiol, 2006, 35(1): 93-99

[4] SaferD.J.. Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. South Med J, 1991, 84(12): 1470-1474

[5] WaddenT.A., ButrynM.L., ByrneK.J.. Efficacy of lifestyle modification for long-term weight control. Obes Res, 2004, 12(Suppl): 151S-162S

[6] PuzziferriN., BlankenshipJ., WolfeB.M.. Surgical treatment of obesity. Endocrine, 2006, 29(1): 11-19

[7] BuchwaldH., WilliamsS.E.. Bariatric surgery worldwide 2003. Obes Surg, 2004, 14(9): 1157-1164

[8] ChristouN.V., SampalisJ.S., LibermanM., et al.. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg, 2004, 240(3): 416-423

[9] SteinertR.E., PollerB., CastelliM.C., et al.. Oral administration of glucagon-like peptide 1 or peptide YY 3–36 affects food intake in healthy male subjects. Am J Clin Nutr, 2010, 92(4): 810-817

[10] OchnerC.N., GibsonC., ShanikM., et al.. Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond), 2011, 35(2): 153-166

[11] WrenA.M., SmallC.J., WardH.L., et al.. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology, 2000, 141(11): 4325-4328

[12] CohenR., UzzanB., BihanH., et al.. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg, 2005, 15(7): 1501-1512

[13] ThomasS., SchauerP.. Bariatric surgery and the gut hormone response. Nutr Clin Pract, 2010, 25(2): 175-182

[14] StraderA.D.. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav, 2006, 88(3): 277-282

[15] HoldstockC., ZetheliusB., SundbomM., et al.. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond), 2008, 32(11): 1640-1646

[16] PatritiA., FacchianoE., GullàN., et al.. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg, 2007, 245(1): 157-158

[17] FrezzaE.E., Chiriva-InternatiM., WachtelM.S.. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today, 2008, 38(6): 481-483

[18] WangY., LiuJ.. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg, 2009, 19(3): 357-362

[19] HimpensJ., DapriG., CadièreG.B.. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg, 2006, 16(11): 1450-1456

[20] Moon HanS., KimW.W., OhJ.H.. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg, 2005, 15(10): 1469-1475

[21] LangerF.B., Reza HodaM.A., BohdjalianA., et al.. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg, 2005, 15(7): 1024-1029

[22] MichelettoG., BadialiM., DanelliP.G., et al.. The biliointestinal bypass: a thirty-year experience. Ann Ital Chir, 2008, 79(6): 419-426

[23] CleatorI.G., PolyakovG., BirminghamC.L.. Ileogastrostomy or jejunoileal bypass with drainage of the bypassed bowel into the stomach. Eur J Gastroenterol Hepatol, 1999, 11(2): 85-88

[24] Dell’AnnaB., ZannoniM., De LorenzisG.. Changes in the principal biohumoral parameters after jejuno-ileal bypass in rats with experimentally induced obesity. Acta Biomed Ateneo Parmense, 1982, 53(2): 51-58

[25] VågeV., SolhaugJ.H., BerstadA., et al.. Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients. Obes Surg, 2002, 12(3): 312-318

[26] FrezzaE.E., Chiriva-InternatiM.. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today, 2008, 38(6): 481-483

[27] PournarasD.J., Le RouxC.W.. The effect of bariatric surgery on gut hormones that alter appetite. Diabetes Metab, 2009, 35(6pt2): 508-512

[28] PournarasD.J., OsborneA., HawkinsS.C., et al.. The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes Surg, 2010, 20(1): 56-60

[29] NäslundE., GrybäckP., HellströmP.M., et al.. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord, 1997, 21(5): 387-392

[30] Alvarez BartoloméM., BorqueM., Martinez-SarmientoJ., et al.. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg, 2002, 12(3): 324-327

[31] DoucetE.. Gastrointestinal peptides after bariatric surgery and appetite control: are they in tuning?. Curr Opin Clin Nutr Metab Care, 2008, 11(5): 645-650

[32] BorgC.M., le RouxC.W., GhateiM.A., et al.. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg, 2007, 17(9): 1193-1198

[33] ReinehrT., RothC.L., SchernthanerG.H., et al.. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg, 2007, 17(12): 1571-1577

[34] BorgC.M., le RouxC.W., GhateiM.A., et al.. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg, 2006, 93(2): 210-215